{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T06:24:46Z","timestamp":1756189486333},"reference-count":38,"publisher":"RCN Publishing Ltd.","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,30]]},"DOI":"10.7748\/ns.2022.e12053","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T09:30:05Z","timestamp":1669023005000},"page":"29-34","source":"Crossref","is-referenced-by-count":3,"title":["Understanding the role of genomics in nursing practice"],"prefix":"10.7748","volume":"37","author":[{"given":"Jodie","family":"Coulson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4499","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"issue":"1","key":"key20221129090247_R1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.tips.2016.11.003","article-title":"Genomics of adverse drug reactions","volume":"38","year":"2017","journal-title":"Trends in Pharmacological Sciences"},{"issue":"2","key":"key20221129090247_R2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7748\/cnp.20.2.17.s10","article-title":"Cancer nursing and genomics","volume":"20","year":"2021","journal-title":"Cancer Nursing Practice"},{"key":"key20221129090247_R3","unstructured":"Blackburn L, Babb de Villiers C, Janus J\n et al (2020) Genomic Innovation: Technologies for Personalised Medicine. www.ahsnnetwork.com\/wp-content\/uploads\/2020\/07\/FINAL-AHSN-full-report.pdf (Last accessed: 4 November 2022.)"},{"key":"key20221129090247_R4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nedt.2018.06.032","article-title":"Increasing nursing capacity in genomics: overview of existing global genomics resources","volume":"69","year":"2018","journal-title":"Nurse Education Today"},{"issue":"11","key":"key20221129090247_R5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/genes9110538","article-title":"Cystic fibrosis gene therapy: looking back, looking forward","volume":"9","year":"2018","journal-title":"Genes"},{"key":"key20221129090247_R6","first-page":"152","volume-title":"The Textbook of Non-Medical Prescribing","year":"2020","edition":"Third edition"},{"key":"key20221129090247_R7","unstructured":"Department of Health and Social Care, Department for Business, Energy & Industrial Strategy, Office for Life Sciences et al (2020) Genome UK: The Future of Healthcare. www.gov.uk\/government\/publications\/genome-uk-the-future-of-healthcare (Last accessed: 4 November 2022.)"},{"issue":"8","key":"key20221129090247_R8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/medethics-2018-105229","article-title":"Familial genetic risks: how can we better navigate patient confidentiality and appropriate risk disclosure to relatives?","volume":"45","year":"2019","journal-title":"Journal of Medical Ethics"},{"key":"key20221129090247_R9","unstructured":"Genetic Alliance UK (2019) Genome Sequencing and the NHS: The Views of Rare Disease Patients and Carers. geneticalliance.org.uk\/wp-content\/uploads\/2019\/07\/Patient-Experience-100000GP.pdf (Last accessed: 4 November 2022.)"},{"key":"key20221129090247_R10","unstructured":"Genomics England (2022) 100,000 Genomes Project. www.genomicsengland.co.uk\/initiatives\/100000-genomes-project (Last accessed: 4 November 2022.)"},{"key":"key20221129090247_R11","unstructured":"Health Education England (2017) Genomics and the Angelina Jolie Effect. www.genomicseducation.hee.nhs.uk\/blog\/genomics-and-the-angelina-jolie-effect (Last accessed: 4 November 2022.)"},{"key":"key20221129090247_R12","unstructured":"Health Education England (2020a) Genetic Conditions. www.genomicseducation.hee.nhs.uk\/doc-type\/genetic-conditions (Last accessed: 4 November 2022.)"},{"key":"key20221129090247_R13","unstructured":"Health Education England (2020b) Cystic Fibrosis. www.genomicseducation.hee.nhs.uk\/documents\/cystic-fibrosis (Last accessed: 4 November 2022.)"},{"key":"key20221129090247_R14","unstructured":"Health Education England (2021) NHS Launches New Polygenic Risk Scores for Heart Disease. www.genomicseducation.hee.nhs.uk\/blog\/nhs-launches-new-polygenic-scores-trial-for-heart-disease (Last accessed: 4 November 2022.)"},{"key":"key20221129090247_R15","unstructured":"Health Education England (2022a) The Genomics Conversation. www.genomicseducation.hee.nhs.uk\/about-us\/the-genomics-conversation (Last accessed: 4 November 2022.)"},{"key":"key20221129090247_R16","unstructured":"Health Education England (2022b) HEE Genomics Education Programme. www.genomicseducation.hee.nhs.uk (Last accessed: 4 November 2022.)"},{"key":"key20221129090247_R17","unstructured":"Health Research Authority (2020) Gene Therapy Advisory Committee. www.hra.nhs.uk\/about-us\/committees-and-services\/res-and-recs\/gene-therapy-advisory-committee (Last accessed: 4 November 2022.)"},{"key":"key20221129090247_R18","first-page":"884","article-title":"Integrating somatic and germline next-generation sequencing into routine clinical oncology practice","volume":"5","year":"2021","journal-title":"JCO Precision Oncology"},{"key":"key20221129090247_R19","unstructured":"Human Fertilisation and Embryology Authority (2022) Approved PGT-M and PTT Conditions. www.hfea.gov.uk\/treatments\/embryo-testing-and-treatments-for-disease\/approved-pgt-m-and-ptt-conditions (Last accessed: 4 November 2022.)"},{"key":"key20221129090247_R20","volume-title":"British National Formulary. No. 84","author":"Joint Formulary Committee","year":"2022"},{"issue":"3","key":"key20221129090247_R21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/ijn.12431","article-title":"A strategy for implementing genomics into nursing practice informed by three behaviour change theories","volume":"22","year":"2016","journal-title":"International Journal of Nursing Practice"},{"issue":"5","key":"key20221129090247_R22","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/jamapediatrics.2022.0187","article-title":"Rapid point-of-care genotyping to avoid aminoglycoside-induced ototoxicity in neonatal intensive care","volume":"176","year":"2022","journal-title":"JAMA Pediatrics"},{"key":"key20221129090247_R23","volume-title":"Clinical guideline No. 71","author":"National Institute for Health and Care Excellence","year":"2019"},{"issue":"2","key":"key20221129090247_R24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.siny.2007.12.004","article-title":"Ethical aspects arising from non-invasive fetal diagnosis","volume":"13","year":"2008","journal-title":"Seminars in Fetal & Neonatal Medicine"},{"key":"key20221129090247_R25","unstructured":"NHS (2022) NHS Genomics Medicine Service. www.england.nhs.uk\/genomics\/nhs-genomic-med-service (Last accessed: 4 November 2022.)"},{"key":"key20221129090247_R26","volume-title":"Future Nurse: Standards of Proficiency for Registered Nurses","author":"Nursing and Midwifery Council","year":"2018"},{"issue":"1","key":"key20221129090247_R27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/bmb\/ldy008","article-title":"Genetic counselling in the era of genomic medicine","volume":"126","year":"2018","journal-title":"British Medical Bulletin"},{"issue":"8","key":"key20221129090247_R28","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.gim.2022.04.023","article-title":"A nationally agreed cross-professional competency framework to facilitate genomic testing","volume":"24","year":"2022","journal-title":"Genetics in Medicine"},{"key":"key20221129090247_R29","unstructured":"Public Health England (2013) Sickle Cell and Thalassaemia (SCT) Screening: Programme Overview. www.gov.uk\/guidance\/sickle-cell-and-thalassaemia-screening-programme-overview (Last accessed: 4 November 2022.)"},{"key":"key20221129090247_R30","unstructured":"Public Health England (2021) Screening for Down\u2019s Syndrome, Edwards\u2019 Syndrome and Patau\u2019s Syndrome: NIPT. www.gov.uk\/government\/publications\/screening-for-downs-syndrome-edwards-syndrome-and-pataus-syndrome-non-invasive-prenatal-testing-nipt\/screening-for-downs-syndrome-edwards-syndrome-and-pataus-syndrome-nipt (Last accessed: 4 November 2022.)"},{"issue":"9","key":"key20221129090247_R31","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3390\/jpm12091358","article-title":"Nurses\u2019 knowledge, attitudes, confidence, and practices with genetics and genomics: a theory-informed integrative review protocol","volume":"12","year":"2022","journal-title":"Journal of Personalized Medicine"},{"issue":"5","key":"key20221129090247_R32","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/cpt.1304","article-title":"Clinical pharmacogenetics implementation consortium guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update","volume":"105","year":"2019","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"key20221129090247_R33","first-page":"7961","article-title":"Cancer pharmacogenomics testing: are we hitting the mark?","volume":"308","year":"2022","journal-title":"Pharmaceutical Journal"},{"issue":"16","key":"key20221129090247_R34","doi-asserted-by":"crossref","first-page":"dev150888","DOI":"10.1242\/dev.150888","article-title":"Gene editing in human development: ethical concerns and practical applications","volume":"145","year":"2018","journal-title":"Development"},{"issue":"2","key":"key20221129090247_R35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.7861\/clinmedicine.14-2-117","article-title":"Ten years of the national genetic diabetes nurse network: a model for the translation of genetic information into clinical care","volume":"14","year":"2014","journal-title":"Clinical Medicine"},{"key":"key20221129090247_R36","volume-title":"Gene Therapy: An Overview of Approved and Pipeline Technologies","year":"2018"},{"issue":"3","key":"key20221129090247_R37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/medethics-2012-101062","article-title":"Discovering misattributed paternity in genetic counselling: different ethical perspectives in two countries","volume":"40","year":"2014","journal-title":"Journal of Medical Ethics"},{"issue":"9","key":"key20221129090247_R38","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.nurpra.2021.07.001","article-title":"Pharmacogenetics in practice: drug management amidst rare genomic testing","volume":"17","year":"2021","journal-title":"Journal for Nurse Practitioners"}],"container-title":["Nursing Standard"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.rcni.com\/doi\/pdf\/10.7748\/ns.2022.e12053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T19:58:15Z","timestamp":1705003095000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.rcni.com\/doi\/10.7748\/ns.2022.e12053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,21]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,11,21]]},"published-print":{"date-parts":[[2022,11,30]]}},"alternative-id":["10.7748\/ns.2022.e12053"],"URL":"https:\/\/doi.org\/10.7748\/ns.2022.e12053","relation":{},"ISSN":["0029-6570","2047-9018"],"issn-type":[{"value":"0029-6570","type":"print"},{"value":"2047-9018","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,21]]}}}